Parkinson’s Disease / 2018 / Article / Tab 1

Research Article

Pisa Syndrome in Parkinson’s Disease: Evidence for Bilateral Vestibulospinal Dysfunction

Table 1

Clinical and electrophysiological data (y = years; M = males; F = females; mg = milligrams; ms = millisecond; mcV = microVolt; LTF = lateral trunk flexion; R = right; L = left; LEDD = levodopa equivalent daily dose; n.s. = statistically nonsignificant). Data are expressed as mean ± standard deviation (SD).

PDPS ()PD ()HC ()

Age (y)73.3 ± 3.669.6 ± 7.1169.36 ± 6.67n.s.
Gender (M/F)8/77/815/15n.s.
Disease duration (y)8.7 ± 4.44.6 ± 3.83
UPDRS II12.4 ± 2.86.2 ± 3
UPDRS III30 ± 6.118.9 ± 6.1
LTF (°)21 ± 9
Side of LTF (R/L)7/8
LEDD (mg)814 ± 275369 ± 202
Normal cVEMPs48%68%97%
Unilateral absence of cVEMPs12%26%0%
Bilateral absence of cVEMPs40%6%3%
P13 latencies (ms)17.8 ± 10.8214.32 ± 3.316.07 ± 8.97n.s.
N23 latencies (ms)26.53 ± 10.2822.68 ± 4.225.77 ± 10.48n.s.
P13 amplitudes (mcV)46.18 ± 29.8841.92 ± 37.7540.57 ± 26.1n.s.
N23 amplitudes (mcV)−44.9 ± 35.26−54.6 ± 34.01−63.16 ± 42.31n.s.
Interpeak latencies (ms)8.6 ± 2.58.5 ± 2.39.6 ± 3.4n.s.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.